首页|期刊导航|皮肤性病诊疗学杂志|系统型种痘样水疱病样淋巴增殖性疾病继发噬血细胞综合征1例及文献复习

系统型种痘样水疱病样淋巴增殖性疾病继发噬血细胞综合征1例及文献复习OA

Hemophagocytic lymphohistiocytosis syndrome secondary to systemic hydroa vacciniforme lymphoproliferative disorder:a case report and literature review

中文摘要英文摘要

目的 通过报告1例系统型种痘样水疱病样淋巴增殖性疾病(系统型HVLPD)继发噬血细胞综合征(HLH)的病例,并对国内外相关文献进行复习,提高对该病的认识.方法 收集患者临床资料、实验室检查、组织病理、免疫组化、TCR基因重排、全外显子基因测序结果并进行分析.结果 患者男,19岁.因全身泛发丘疹、丘疱疹、坏死结痂伴发热7个月入院.患者临床表现为种痘样水疱病样皮疹,淋巴结及脾大,血细胞减少、高甘油三酯血症、NK细胞活性降低、可溶性白细胞介素-2受体升高,VCA-IgA和EA-IgA阳性,EBV-DNA定量高,全外显子测序未见致病性基因突变.组织病理:表皮和毛囊基底层细胞液化变性,色素失禁,淋巴细胞进入表皮和毛囊上皮,真皮全层血管和毛囊周围大量淋巴细胞、嗜酸性粒细胞浸润,大量红细胞外溢,皮肤附件及小血管周围见异型淋巴样细胞呈灶状浸润,可见核分裂像.免疫组化:CD3(+),CD5(+),CD20(个别+),CD30(小片状+),CD79a(个别+),CD4(+),CD7(+),CD8(+),TIA-1(+),CD56(散在个别淋巴细胞+),Ki-67 约 50%,原位杂交 EBER(+).TCRβ基因检测到单克隆重排.结合临床及辅助检查诊断为系统型HVLPD继发HLH.随访8个月后,患者在等待异基因造血干细胞移植过程中死亡.结论 系统型HVLPD少见,需要警惕继发HLH.临床医生提高对本病的认识可避免漏诊误诊,避免延误治疗.

Objective To report a case of hemophagocytic lymphohistiocytosis syndrome(HLH)secondary to systemic hydroa vacciniforme lymphoproliferative disorder(systemic HV-LPD)and review relevant literature,in order to improve understanding of the disease.Methods Clinical data of the case,laboratory examination,histopathology,immunohistochemistry,TCR gene rearrangement,and whole exon gene sequencing were collected for analyses.Results A 19 years old man was admitted to the hospital due to generalized papules,blisters,necrotic scabs and fever for 7 months.The clinical manifestations included hydroa vacciniforme-like rashes,lymphad-enopathy,splenomegaly,pancytopenia,hypertriglyceridemia,decreased NK cell activity,high levels of sIL-2r,positive for VCA-IgA and EA-IgA,and elevated EBV DNA load.The whole exon sequencing did not show pathogenic gene mutations.Histopathological changes in the skin lesions included liquefaction degeneration of epidermal and follicular basal cells,pigmentary inconti-nence,lymphocytic infiltrates of the epidermis and follicular epithelium,perivascular and perifol-licular infiltrates of lymphocytes and eosinophils in the dermis,extravasation of erythrocytes,as well as focal infiltrates of atypical lymphoid cells around appendages and small blood vessels.Pathologic mitosis was visible.Immunohistochemistry showed CD3(+),CD5(+),CD20(in-dividual+),CD30(small patch+),CD79a(individual+),CD4(+),CD7(+),CD8(+),TIA-1(+),CD56(scattered lymphocyte+),≈50%of Ki-67(+),and in situ hybrid-ization EBER(+).TCRβ gene monoclonal rearrangements were detected.According to the re-sults of clinical and auxiliary examination,patient was diagnosed with HLH secondary to systemic HVLPD.After 8 months of follow-up,the patient passed away while waiting for transplantation of allogeneic hematopoietic stem cells.Conclusions Systemic HVLPD is rare and requires vigilance for the development of secondary hemophagocytic syndrome.The awareness of hemophagocytic syndrome should be improved to avoid possible misdiagnosis and delayed treatment.

杨赛;Heidari Mohammmad Hassan;薛汝增;罗颖;陈嵘袆;陈永锋;梁云生

南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091南方医科大学皮肤病医院,广东 广州 510091

系统型种痘样水疱病样淋巴增殖性疾病噬血细胞综合征EBV

hydroa vacciniforme lymphoproliferative disorderhemophagocytic lymphohistio-cytosis syndromeEBV

《皮肤性病诊疗学杂志》 2024 (2)

102-108,7

10.3969/j.issn.1674-8468.2024.02.006

评论